Two Sigma Investments
JBIO

Two Sigma Investments’s Jade Biosciences JBIO Stock Holding History

Two Sigma Investments’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$256K Buy
18,251
+1,755
+11% +$25.4K ﹤0.01% 4163
2025
Q4 		$255K Sell
16,496
-8,114
-33% -$95.2K ﹤0.01% 3662
2025
Q3 		$212K Buy
+24,610
New +$201K ﹤0.01% 3359
2025
Q2 		– Sell
-5,851
Closed -$514K – 3183
2025
Q1 		$514K Sell
5,851
-610
-9% -$53.6K ﹤0.01% 2511
2024
Q4 		$599K Sell
6,461
-2,485
-28% -$214K ﹤0.01% 2452
2024
Q3 		$654K Buy
8,946
+980
+12% +$63.2K ﹤0.01% 2341
2024
Q2 		$463K Buy
7,966
+7,311
+1,116% +$4.85M ﹤0.01% 2408
2024
Q1 		$678K Buy
655
+376
+135% +$287K ﹤0.01% 2186
2023
Q4 		$221K Sell
279
-58
-17% -$29.6K ﹤0.01% 2803
2023
Q3 		$160K Sell
337
-520
-61% -$282K ﹤0.01% 2679
2023
Q2 		$515K Buy
857
+528
+160% +$338K ﹤0.01% 2318
2023
Q1 		$232K Sell
329
-275
-46% -$228K ﹤0.01% 2512
2022
Q4 		$619K Buy
+604
New +$439K ﹤0.01% 1929

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Two Sigma Investments's JBIO Position: Q1 2026 in Review

Two Sigma Investments increased its Jade Biosciences (JBIO) stake by 11% in Q1 2026, buying an estimated $25.4K and bringing the position to 18,251 shares worth $256K. The position accounts for ﹤0.01% of the portfolio, ranked #4163.

Two Sigma Investments first reported a position in JBIO in Q4 2022 and has held it in 13 quarters since. The position peaked at $678K in Q1 2024. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Two Sigma Investments held 18,251 shares of Jade Biosciences worth $256K as of Q1 2026.
  • Two Sigma Investments bought 1,755 Jade Biosciences shares in Q1 2026, an estimated $25.4K.
  • Jade Biosciences made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4163 holding.
  • Two Sigma Investments first reported a position in Jade Biosciences in Q4 2022 and has held it in 13 quarters since.
  • Two Sigma Investments's Jade Biosciences position peaked at $678K in Q1 2024.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.